[Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007621:Karyotyping; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000235:genetics; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000097:blood*; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
Leucemia acute linfoblastica L3 in corso di morbo di Hodgkin in remissione: leucosi primitiva o secondaria?